Preladenant Completed Phase 3 Trials for Idiopathic Parkinson's Disease / Parkinson's Disease (PD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01227265Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)